Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction
Abstract
The 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol identified patients with recent (past 12 months) myocardial infarction (MI) as very high risk, in whom a PCSK9 inhibitor is reasonable to add to maximally tolerated statin combined with ezetimibe if their low-density lipoprotein cholesterol level is 70 mg/dL or greater or non-high-density lipoprotein cholesterol level...
Paper Details
Title
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction
Published Date
Aug 1, 2020
Journal
Volume
5
Issue
8
Pages
952 - 952
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History